• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX
Click for more information
11.2% $4.38

MAYNE PHARMA GROUP LIMITED - Charts / Financials

Market Cap $372.6M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 23/08/2024 (20 minute delay) ?
Day
Open $4.40   Day High $4.79   Day Low $4.18
Daily Volume 590114
Bids   Sellers
Number Price Volume   Number Price Volume
1 $4.35 1271   1 $4.44 1271

Directors & Senior Management

Mr. Shawn Patrick O' Brien Chief Executive Officer, Managing Director, Executive Director
Mr. Aaron Gray Chief Financial Officer
Ms. Laura Loftus Company Secretary
Mr. Frank C. Condella Non-Executive Independent Chairman of the Board
Ms. Anne Nicole Lockwood Non-Executive Director
Mr. David Petrie Non-Executive Director
Mr. Patrick J. Blake Independent Non-Executive Director
Ms. Ann Custin Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$4.38 		Change
0.440(11.2%) 		Mkt cap ! $372.6M
Open High Low Value Volume
$4.40 $4.79 $4.18 $2.649M 590.1K

Buyers (Bids)

No. Vol. Price($)
1 1271 $4.35
 

Sellers (Offers)

Price($) Vol. No.
$4.44 1271 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
$4.38 		  Change
0.440 ( 11.0 %)
Open High Low Volume
$4.42 $4.79 $4.21 26856
Last updated 15.59pm 23/08/2024 ?

Top Stories

The Rising Tide: How institutional adoption is shaping the future of crypto

This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.